Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model by Lipinska, Urszula et al.
Panton-Valentine Leukocidin Does Play a Role in the
Early Stage of Staphylococcus aureus Skin Infections: A
Rabbit Model
Urszula Lipinska1*, Katleen Hermans1, Lieve Meulemans1, Oana Dumitrescu3,4,5, Cedric Badiou3,4,
Luc Duchateau2, Freddy Haesebrouck1, Jerome Etienne3,4,5, Gerard Lina3,4,5
1Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium, 2Department of Physiology and
Biometry, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium, 3Centre National de Re´fe´rence des Staphylocoques, Universite´ Lyon 1, Lyon, France,
4 INSERM U851, IFR128, Lyon, France, 5Hospices Civils de Lyon, Lyon, France
Abstract
Despite epidemiological data linking necrotizing skin infections with the production of Panton-Valentine leukocidin (PVL),
the contribution of this toxin to the virulence of S. aureus has been highly discussed as a result of inconclusive results of in
vivo studies. However, the majority of these results originate from experiments using mice, an animal species which
neutrophils - the major target cells for PVL - are highly insensitive to the action of this leukocidin. In contrast, the rabbit
neutrophils have been shown to be as sensitive to PVL action as human cells, making the rabbit a better experimental
animal to explore the PVL role. In this study we examined whether PVL contributes to S. aureus pathogenicity by means of a
rabbit skin infection model. The rabbits were injected intradermally with 108 cfu of either a PVL positive community-
associated methicillin-resistant S. aureus isolate, its isogenic PVL knockout or a PVL complemented knockout strain, and the
development of skin lesions was observed. While all strains induced skin infection, the wild type strain produced larger
lesions and a higher degree of skin necrosis compared to the PVL knockout strain in the first week after the infection. The
PVL expression in the rabbits was indirectly confirmed by a raise in the serum titer of anti-LukS-PV antibodies observed only
in the rabbits infected with PVL positive strains. These results indicate that the rabbit model is more suitable for studying
the role of PVL in staphylococcal diseases than other animal models. Further, they support the epidemiological link between
PVL producing S. aureus strains and necrotizing skin infections.
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Introduction
Staphylococcus aureus is a potent human pathogen causing various
medical conditions, from minor skin infections (i.a. pimples,
impetigo, abscesses) to life-threatening diseases (i.a. bacteraemia,
endocarditis and sepsis) [1]. The capacity of S. aureus to evoke such
a wide range of clinical manifestations may be attributed to the
production of numerous exoproteins. One of them, Panton-
Valentine leukocidin (PVL), is a two-component (LukS-PV and
LukF-PV), pore-forming toxin with affinity for neutrophils and
macrophages - cells responsible for the first line defence against
invading bacteria [2–5]. Epidemiologically, PVL-producing strains
have been linked with necrotizing ‘skin and soft tissues infections’
(SSTI) already in the 1990s [6–10]. More recently, the emergence
of community-associated methicillin-resistant S. aureus (CA-
MRSA) strains containing PVL determinants and their association
with a rapid growing number of skin infections [11], severe
necrotising pneumonia [12] and necrotizing fasciitis [13] raised an
interest in the importance of PVL in staphylococcal infections.
One of the first in vivo studies evaluating the role of PVL in
staphylococcal skin infections showed that intradermal injection of
PVL provokes widespread and infiltrated erythema followed by
skin necrosis in rabbits [6]. In contrast, subsequent in vivo
experiments using murine models failed to uniformly prove the
PVL contribution to the development of staphylococcal skin
infections [14–17]. The reason for this inconsistency has been
linked to a species-specific susceptibility of the host cells to PVL
[18,19]. Since neutrophils isolated from mice have been reported
to be relatively insensitive to the leukotoxic effect of PVL in
contrast to human and rabbit cells [2,18], the latter has been
postulated to be a better model for studying the role of PVL
[18,19].
Therefore, we employed a rabbit skin infection model in order
to evaluate the contribution of PVL to the pathogenicity of the S.
aureus USA300 strain, a predominant cause of community-
associated staphylococcal infections in Northern America [20],
using isogenic PVL positive and negative strains.
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Materials and Methods
Bacterial strains and culture
To provide optimal conditions for the production of PVL, all
strains used in this study were cultivated in CCY medium [3].
LAC is a USA300 pulsotype community-associated methicillin
resistant S. aureus (CA-MRSA) isolate, LACDpvl is its isogenic PVL
knockout strain constructed as described elsewhere [14].
LUG1515 was obtained by trans-complementation of PVL in
the LACDpvl strain using a pLUG534 plasmid [21]. To support
plasmid maintenance, all growth media for the LUG1515 strain
were supplemented with chloramphenicol (10 mg/ml).
To prepare the bacterial inoculum, a single colony was
propagated in 5 ml of casein hydrolysate and yeast extract
medium (CCY) medium with constant shaking at 200 revolutions
per minute (rpm) at 37uC. The overnight culture was diluted 1:200
in CCY, incubated till the mid-exponential growth phase
(OD600 = 0.8) and harvested by centrifugation. The pelleted
bacteria were washed once, resuspended in sterile phosphate
buffered saline (PBS) to a concentration of about 26109 colony-
forming units (cfu) per ml and immediately used for inoculation.
The exact number of bacteria used was determined by plating out
serial dilutions of the inocula.
Experimental animals
Thirty-three twelve-week-old albino hybrid rabbits of either sex,
weighing 2.5–3 kg, were purchased from ILVO (Melle, Belgium).
These animals do not carry rabbit-associated high virulence S.
aureus strains evoking i.a. skin lesions, as was confirmed by the
absence of such strains in swab samples taken from nine different
body sites from all animals [22,23]. The rabbits were divided
randomly into three groups of eleven animals, which were kept in
separate HEPA-filtered rooms with negative pressure and light-
dark cycles of 12 h per 12 h. The rabbits were housed individually
with water and feed provided ad libitum.
Experimental design
From each animal 4 ml of blood was collected from the
marginal ear vein before the onset of the experiment. On the day
of the infection, the hair on the right flank of each rabbit was
shaved with electric clippers (Wella Contura Hair Clipper, Wella)
and the skin was disinfected thoroughly with 70% ethanol (Chem-
Lab NV, Zedelgem, Belgium). After evaporation of the ethanol,
50 ml of PBS containing 108 cfu of either the knockout strain
LACDpvl, the PVL producing strain LAC or the complemented
strain LUG1515 were injected intradermally in the right flank of
the rabbits of the respective groups.
During the following 14 days the behavior of the animals and
their rectal temperature were examined daily, and the appearance
of the lesions was noted. Width and length of the lesions and the
necrotic areas were measured, and their surface was calculated as
described earlier [15], using the formula A~p l|wð Þ=2, where A
is a surface, l is a length and w is a width of the lesion. At day 4
after inoculation (p.i.) three randomly selected animals per group
were euthanized. Skin biopsies from the inoculation site were
taken aseptically and preserved until further analysis. From the
remaining animals, blood samples were collected at day 21 p.i.,
preceding euthanasia and collection of skin biopsies.
The experimental protocol was approved by the ethical
committee of the Faculties of Veterinary Medicine and Bioscience
Engineering, Ghent University (permit number 2009_121). The
animal studies were performed following the EU legislation being
the Council Directive 86/609 EEC covering the protection of
animals used for experimental and other scientific purposes.
Housing and care of the rabbits was in conformity with the
adapted Appendix A of the European Convention ETS 123 of the
council of Europe, as approved by the multilateral consultation in
2007.
Histological analysis
Following fixation in 10% buffered formalin, the skin samples
were dehydrated with increasing concentrations of ethanol,
cleared with Histosolve (Thermo Shandon, Pittsburgh, PA) and
embedded in paraffin. Four microns sections were used to perform
hematoxylin-eosin staining. All samples were examined by light
microscopy in the absence of any information about their origin.
Hematoxylin-eosin stained sections were evaluated according to
the following parameters: degree of dermal necrosis, degree of
dermal inflammation and inflammatory cell type, degree of fibrosis
and epidermal changes present.
Detection of anti-PVL antibodies
Blood samples collected during the experiment were incubated
for 30 min at room temperature in glass tubes with inert gel
barrier and activated disc (Venoject VT109SAS, Terumo). Next,
the sera were separated by centrifugation at 1500 rpm for 10 min
and stored at 220uC until use.
Antibodies against PVL (before S. aureus challenge and at
sacrifice) were measured in rabbit sera using an ELISA protocol
adapted from Croze et al. [24], with a peroxidase-conjugated
swine anti-rabbit polyvalent IgG diluted 1:103 (DAKO). Serial
dilutions of anti-LukS-PV polyclonal rabbit serum (bioMe´rieux)
were used for calibration. The results were expressed in arbitrary
units per liter (AU/L), with one arbitrary unit corresponding to the
amount of anti-LukS-PV antibodies present in a 1:107 dilution of
the polyclonal rabbit reference serum.
Statistical analysis
The comparison between strains with respect to diameter of the
necrotic area, diameter and surface of the lesion was based on the
linear mixed model with strain, time and their interaction as
categorical fixed effects and rabbit as random effect. A global
significance level of 5% was used. For multiple comparisons (the
comparison of the 3 strains at each of the 14 times separately),
Bonferroni’s adjustment technique was used leading to a
comparisonwise significance level of 0:5%= 5|14ð Þ~0:096%.
Antibody levels were compared pairwise between strains at 0
and 21 days after infection using a t-test.
Results
Clinical observations
The rectal temperature registered for all rabbits during the
experiment was within the normal range [25], with an exception of
the first day after the infection. On that day, two animals in group
LACDpvl and one animal in group LUG1515 developed fever
(above 40.6uC).
Despite the developing lesions and the raised temperature on
day 1 p.i., all animals remained alert, showed normal grooming
behavior and appetite throughout the entire experiment.
Macroscopic description of the lesion development
All 33 rabbits developed an inflammatory reaction at the site of
injection of the bacteria within the first 24 h, which within the
following days evolved into fully grown lesions. The lesions
appeared as a central necrotic area surrounded by a region of
inflamed skin. The areas of necrosis became encrusted in all
animals by day 5 p.i. (photos in fig. 1 show the appearance of the
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lesions on day 4). The crusts in the LUG1515 group were situated
deeper in the surrounding inflamed skin (fig. 1C), which was not
the case in the remaining two groups. Periodic loss of the crusts in
all groups revealed purulent material, whereafter a new crust was
formed within the following 24 h. Before the end of the
observation period (day 14 p.i.) the purulent material within the
lesions was replaced by fibrotic scarring tissue.
A graphic overview of the mean surface of the lesions and
necrotic areas in different groups during 14 days after infection is
presented in figure 2.
The maximal mean diameter of the lesions was observed for all
three infection groups on day 3 p.i. and reached 41 (range 7–75),
80 (range 38–115) and 58 mm (range 25–90) in group LACDpvl,
LAC and LUG1515, respectively. On the last day of the
observation the mean diameter of the lesions had decreased to
22 mm (range 10–38) in group LACDpvl, 35 mm (range 15–55) in
group LAC and 30 mm (range 16–63) in group LUG1515. The
mean diameter of the lesions in group LACDpvl was significantly
smaller than in group LAC from day 3 till 6 p.i. (P,0.00096). As
the surface of the lesions is a function of their diameter, a similar
tendency was observed for the mean surface of the lesions, where a
significant difference was observed between group LACDpvl and
LAC from day 3 till 5 p.i. The difference between the surface of
the lesions of group LACDpvl and LUG1515 was significant only
on day 3 p.i.
The maximal mean diameter of the necrotic area was observed
in group LACDpvl on day 6 p.i., in group LAC on day 2 and in
group LUG1515 on day 5, reaching a diameter of 20 (range 7–47),
47 (range 6–92) and 30 mm (range 9–69), respectively. On the last
day of the observation the mean diameter of the dermonecrosis
had decreased to 12 mm in group LACDpvl, 23 in group LAC and
17 in group LUG1515. The mean diameter of the necrotic area in
group LACDpvl was significantly smaller than in group LAC on
day 2 p.i. (P,0.00096). For days 3–7 p.i. the results were similar,
but the difference was not significant. The surface of the
dermonecrosis showed a similar tendency with significant
difference between LACDpvl and LAC on day 2 and 3 p.i., and
similar but not significant results for days 4–6 p.i.
In the course of the experiment one animal in group LACDpvl,
three in group LAC and two in group LUG1515 developed a
secondary lesion on their abdomen. This was possibly a result of
gravity-enhanced transport of the bacteria through the lymphatic
system. Those lesions were not included in the statistical analysis as
there was no physical connection of those lesions with the lesion at
the original inoculation site.
Histological examination
The histopathological changes observed in skin samples
collected from animals euthanized at day 4 p.i. are presented in
table 1, and photos of the representative histological sections are
shown in figure 3.
For rabbits euthanized at the end of the experiment (day 21
p.i.), the following histological findings were noted in the skin. In
all samples from the LACDpvl and LAC inoculated groups there
was a marked epidermal hyperplasia and the dermis showed
moderate to marked fibrosis with mild perivascular infiltrations of
mainly monocytes and lymphocytes. Similar findings were noted
in the LUG1515 group, except for one biopsy where there was
only a mild dermal fibrosis. In three biopsies from each group
some PMNs were present as well. In four LAC, two LUG1515 and
one LACDpvl inoculated skin samples, macrophages were noted.
In one biopsy from the LUG1515 group, an old organised
intravascular thrombus was present.
Detection of anti-PVL antibodies in the sera
The distribution of the titers of the anti-PVL antibodies detected
in the sera collected from the rabbits from LACDpvl, LAC and
LUG1515 group before challenge and at euthanasia are presented
in figure 4.
There was no statistical difference between the groups in the
titer of anti-PVL antibodies in the sera collected before challenge.
While in group LACDpvl there was no statistical difference in the
level of antibody before infection and at day 21 p.i., in group LAC
and LUG1515 the mean antibody titers were significantly higher
in the samples collected at the end of the experiment (8.4 and 19.6
times, respectively).
Figure 1. The appearance of lesions on day 4 after infection. The appearance of the lesions on day 4 p.i. in rabbits infected with LACDpvl (1–
11), LAC (12–22) and LUG1515 (23–33). The unit of length of used measuring rod is centimetre.
doi:10.1371/journal.pone.0022864.g001
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Discussion
Involvement of PVL in the virulence of S. aureus has been a
controversial topic for many scientists searching for factors
responsible for the high pathogenicity of community associated
S. aureus strains. Inasmuch as murine models have been delivering
inconclusive results on the PVL contribution to the staphylococcal
skin infections, we examined the role of this toxin using a rabbit -
an animal species whose neutrophils are as sensitive to the action
of PVL as those of humans [18]. We found that the CA-MRSA
USA300 isolate expressing PVL produced lesions with significantly
bigger surface than the isogenic PVL knockout strain in the first
week after inoculation. Those data suggest that PVL has an impact
on the early development of S. aureus skin infections in rabbits. In
line with our results are the conclusions drawn from other studies
investigating the role of PVL in rabbit models. Diep et al. depicted
a modest, but measurable role of PVL in the pathogenesis during
the early stages of bacteremic seeding in the kidney [26], and
Cremieux et al. demonstrated PVL contribution to the local
extension of osteomyelitis during the early phase of bone infection
[27]. With regard to skin infections, our results are the first
showing the capability of PVL producing strain to produce bigger
lesions in rabbits, in comparison to their isogenic PVL knockout.
Recently, Li et al. published a study showing that rabbits
infected with another USA300-type isolate produced lesions with a
surface corresponding to that observed in our study in animals
infected with LAC [28]. However, in the same study a PVL
negative USA500 isolate evoked comparable lesions, which
prompted the authors to the conclusion that PVL does not
contribute to the development of skin lesions. The variation
between the conclusions of the above mentioned and our study
could be attributed to the study set up. While strains used in our
study varied only upon PVL expression, those used by Li et al.
may differ in respect to other determinants as well. Moreover, the
latter failed to detect any PVL mRNA by qRT-PCR in the
abscesses of PVL positive strains in their experimental model.
As the PVL determinants have been linked with necrotizing
infections, the development of skin necrosis was evaluated during
our study. The animals in all experimental groups initially
developed necrotic lesions in the place of injection of bacteria.
Interestingly, the majority of animals inoculated with the PVL
knockout strain developed skin necrosis restricted to the
surrounding of the inoculation spot. In contrast, the animals
injected with PVL producing strains (LAC and LUG1515)
developed necrotic lesions largely exceeding the inoculation area,
suggesting that PVL activity accounts for development of severe
Figure 2. The size of the lesions and skin necrosis over the time. Mean surface of the lesions (a) and necrotic areas (b) evoked by intradermal
injection of LAC (D), LACDpvl (o) and LUG1515 (x) in the rabbits. Asterisk (*) represents a statistically significant result in comparison to LACDpvl
group.
doi:10.1371/journal.pone.0022864.g002
Table 1. Histopathological changes in rabbit skin produced by PVL-positive or -negative S. aureus strains.
Rabbit belonging
to group Necrosis Inflammation Remarks
location level location level cell type
LACDpvl dermis ++ dermis ++ PMN ++, MF +/2, LF +/2
muscle 2 muscle + PMN +/2, MF +
LACDpvl dermis +++ dermis +++ PMN +++, MF +/2, LF +/2
muscle 2 muscle + PMN +/2, MF +
LACDpvl dermis +++ dermis +++ PMN +++, MF +, LF +
muscle 2 muscle +/2 PMN +/2, MF +
LAC dermis ++++ dermis ++++ PMN ++++, MF +, LF +/2 bacteria observed
muscle +++ muscle +++ PMN ++, MF +
LAC dermis +++++ dermis ++ PMN ++, MF + bacteria observed
muscle +++ muscle +++ PMN +++
LAC dermis +++++ dermis ++++ PMN +++, MF +/2, LF +/2
muscle + muscle ++ PMN +/2, MF +
LUG1515 dermis ++++ dermis ++++ PMN +++, MF +, LF + bacteria observed
muscle +++ muscle ++ PMN ++
LUG1515 dermis ++ dermis +++ PMN +++, MF +/2, LF + bacteria observed
muscle + muscle + PMN +/2, MF +
LUG1515 dermis +++ dermis ++++ PMN +++, MF +, LF +
muscle ++ muscle + PMN +
From animals euthanized at day 4 p.i. lesions samples were used to prepare histological slides and the histopathological changes observed are summarized in the table.
The grading system used was as follows: for necrosis (2) absent, (+) mild, (++) mild to moderate, (+++) moderate, (++++) pronounced, (+++++) severe; for inflammation
(+/2) several inflammatory cells present, (+) mild, (++) moderate, (+++) pronounced and (++++) severe inflammation; presence of specific cell populations (+/2) few
cells present, (+) several, (++) some, (+++) many cells present, (++++) big population of cells observed. Abbreviations: PMN=Polymorphonuclear cells;
MF=macrophages; LF = lymphocytes.
doi:10.1371/journal.pone.0022864.t001
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necrotizing lesions. Obtained results are consistent with those of
Cribier et al. [6] who observed development of skin necrosis in
rabbits injected with purified PVL and observations from a rabbit
model of necrotizing pneumonia where a PVL-producing strain
caused more lung necrosis than its PVL knockout [19]. Moreover,
the histological analysis of skin biopsies collected at day 4 p.i. from
Figure 3. Microscopic appearance of skin lesions on day 4 after infection. The sections of the skin lesions collected from rabbits euthanized
at day 4 p.i. were stained with hematoxylin and eosin, and observed under light microscope. A, C and E present the sections from the skin of rabbits
infected with LACDpvl, LAC and LUG1515, respectively. B, D and F show the appearance of the skin muscle layer in animals inoculated with the strains
mentioned above.
doi:10.1371/journal.pone.0022864.g003
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the inoculation spot revealed slightly more pronounced damage
and inflammatory response in animals infected with PVL positive
S. aureus strains. The fact that some necrosis and inflammation was
observed in the group infected with the PVL knockout strain
indicates that other staphylococcal factors (i.e. phenol-soluble
modulin, a-toxin) may contribute to the lesion development
[28,29]. In conclusion, the presented results endorse the
epidemiological link between PVL-producing strains and necro-
tizing skin infections [6–8,10].
Interestingly, while only minor histopathological differences
have been noted for the dermis, necrosis of the skin muscle layer
was observed for animals infected with PVL positive strains, in
contrast to the PVL knockout where normal muscle was observed.
Similarly, Tseng at al. observed damage of the muscle underlying
inoculation spot in mice infected with high doses of PVL
producing S. aureus [16]. Those data indicate that PVL may
contribute to the damage of both the dermis and the skin muscle
layer during skin infection.
To confirm the fact that differences between the wild type CA-
MRSA strain and its PVL knockout could be accounted to PVL
action, our study included a PVL knockout strain expressing PVL
from a plasmid (LUG1515). Although the lesions produced by that
strain differed macroscopically (smaller, but deeper - see fig. 1 and
fig. 2a) from those evoked by the wild type strain, both strains
produced bigger lesions in the early phase of infection than the
PVL negative strain. Despite the fact that the PVL genes were
accompanied by the original promoter and translator, the
difference in the structure of the lesions produced by the wild
type and the complemented strain could be result of a difference in
the amount of PVL produced.
In order to confirm the in vivo expression of PVL, blood samples
collected from the rabbits were analysed for the presence of
antibodies directed against PVL. The anti-PVL antibody level in
the rabbits infected with the PVL positive strains increased
significantly in the course of the infection, while no shift in the titer
of the antibody was observed for the rabbits infected with the PVL
knockout strain. This raise in the titer of anti-PVL antibody is an
indirect proof for production of this toxin during the infection. In
line with our results are the observations from human patients
where the anti-PVL antibody titers were demonstrated to be
Figure 4. Production of anti-PVL antibodies. Distribution of anti-PVL antibody levels in the sera collected before challenge and at day 21 p.i.
from rabbits infected with LACDpvl, LAC and LUG1515. Bars show the mean value.
doi:10.1371/journal.pone.0022864.g004
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higher in patients with PVL positive S. aureus infection and to rise
4.6 times in the course of a skin infection [24].
Our results indicate that the rabbit is a better model than the
mouse to study the contribution of PVL in the pathogenesis of skin
infections by S. aureus. It is important that attention is paid to use
animals free of high virulence rabbit S. aureus strains [30]. Those
can be isolated from different body sites in carrier rabbits and can
lead to the development of massive skin infection when introduced
into the skin lesion. Through the collection of skin swabs from
rabbits prior to the experiment, followed by bacteriological
examination and molecular analysis of detected staphylococci,
high virulence rabbit S. aureus strains can be identified [23] and
their interference in the studies of human isolates can be avoided.
Although it could be remarked that the evaluation of the lesions
was not performed blinded during this experiment, the significant
difference in the size of the lesions evoked by wild type strain and
its PVL knockout, in combination with the histological observa-
tions, indicate that PVL contributes to the severity of skin
infections evoked by the CA-MRSA USA300 strain. As USA300
type isolates are epidemic in the USA and are responsible for a
growing number of infections worldwide, further studies concern-
ing community-associated staphylococcal infections should not
neglect the impact of PVL.
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